Venture Report: Curie.Bio’s fund; megarounds for Formation, EvolutionaryScale, BillionToOne

Two-year-old investor and accelerator Curie.Bio has raised $380 million to continue building young biotechs, with a goal of preserving equity for founders as they advance high-potential programs.

Established in 2022 by Flatiron Health Inc. co-founder Zach Weinberg and former Third Rock Ventures partners Christoph Lengauer and Alexis Borisy, Curie.Bio has thus far backed 20 start-ups. The firm supplies operational support and drug-hunting assistance to founders, investing small amounts in the nascent projects...